Skip to main content

Research Repository

Advanced Search

Clinical expert guidelines for the management of cough in lung cancer: Report of a UK task group on cough

Molassiotis, Alex; Smith, Jaclyn A.; Bennett, Mike I.; Blackhall, Fiona; Taylor, David; Zavery, Burhan; Harle, Amelie; Booton, Richard; Rankin, Elaine M.; Lloyd-Williams, Mari; Morice, Alyn H.

Authors

Alex Molassiotis

Jaclyn A. Smith

Mike I. Bennett

Fiona Blackhall

David Taylor

Burhan Zavery

Amelie Harle

Richard Booton

Elaine M. Rankin

Mari Lloyd-Williams



Abstract

Background: Cough is a common and distressing symptom in lung cancer patients. The clinical management of cough in lung cancer patients is suboptimal with limited high quality research evidence available. The aim of the present paper is to present a clinical guideline developed in the UK through scrutiny of the literature and expert opinion, in order to aid decision making in clinicians and highlight good practice.Methods: Two systematic reviews, one focusing on the management of cough in respiratory illness and one Cochrane review specifically on cancer, were conducted. Also, data from reviews, phase II trials and case studies were synthesized. A panel of experts in the field was also convened in an expert consensus meeting to make sense of the data and make clinical propositions.Results: A pyramid of cough management was developed, starting with the treatment of reversible causes of cough/specific pathology. Initial cough management should focus on peripherally acting and intermittent treatment; more resistant symptoms require the addition of (or replacement by) centrally acting and continuous treatment. The pyramid for the symptomatic management starts from the simpler and most practical regimens (demulcents, simple linctus) to weak opioids to morphine and methadone before considering less well-researched and experimental approaches.Conclusion: The clinical guidelines presented aim to provide a sensible clinical approach to the management of cough in lung cancer. High quality research in this field is urgently required to provide more evidence-based recommendations. © 2010 Molassiotis et al; licensee BioMed Central Ltd.

Citation

Molassiotis, A., Smith, J. A., Bennett, M. I., Blackhall, F., Taylor, D., Zavery, B., Harle, A., Booton, R., Rankin, E. M., Lloyd-Williams, M., & Morice, A. H. (2010). Clinical expert guidelines for the management of cough in lung cancer: Report of a UK task group on cough. Cough, 6(1), Article 9. https://doi.org/10.1186/1745-9974-6-9

Journal Article Type Review
Acceptance Date Oct 6, 2010
Online Publication Date Oct 6, 2010
Publication Date Oct 6, 2010
Deposit Date May 24, 2022
Publicly Available Date Aug 28, 2024
Journal Cough
Print ISSN 1745-9974
Publisher BioMed Central
Peer Reviewed Peer Reviewed
Volume 6
Issue 1
Article Number 9
DOI https://doi.org/10.1186/1745-9974-6-9
Keywords Morphine; Lung cancer patient; Oxycodone; Hydromorphone; High quality research
Public URL https://hull-repository.worktribe.com/output/3610321

Files

Published article (443 Kb)
PDF

Publisher Licence URL
http://creativecommons.org/licenses/by/2.0

Copyright Statement
© 2010 Molassiotis et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.






You might also like



Downloadable Citations